The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ISHARES INC | MSCI STH KOR ETF | 464286772 | 10,066,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 725,000 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 34,160,400 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | |||
SPDR SER TR | S&P REGL BKG | 78464A698 | 51,185,040 | 1,018,000 | SH | SOLE | 1,018,000 | 0 | 0 |